The manufacturing of the drug will be retained by TJ Biopharma at its site in Hangzhou, which would make felzartamab China’s ...

Biogen heads into Q1 earnings with new drugs like Skyclarys and Zurzuvae driving growth as legacy MS products face rising competitive pressure.

The EMA’s CHMP has stated its positive opinions on three drugs for autoimmune, muscle wasting and rare genetic diseases.

Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...

Stocks are set to close out April with major gains even as a war in the Middle East is ongoing, and fears around AI ...

Thursday, April 23, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth ...

Researchers at Mass General Brigham, the Broad Trauma Initiative , and Harvard T.H. Chan School of Public Health have identified scalable ...

Karin-Mari Dötze lands a Nedbank sponsorship after a Two Oceans Marathon bib-switch scandal briefly cost her a Top 10 finish ...

Evercore ISI upgrades Intel to outperform from in line Evercore upgraded the stock following earnings on Thursday. "Improved ...

MassMEDIC president Brian Johnson proposes using local medtech innovations to address a $1.5 billion MassHealth budget gap ...

Wall Street trading got off to a mixed start on Friday after Donald Trump announced that Israel and Lebanon had agreed to ...